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Intracellular pathogens have devised mechanisms to
exploit their host cells to ensure their survival and
replication. The malaria parasitePlasmodium falcipa-
rum relies on an exchange of metabolites with the
host for proliferation. Here we describe a mass spec-
trometry-based metabolomic analysis of the parasite
throughout its 48 hr intraerythrocytic developmental
cycle. Our results reveal a general modulation of
metabolite levels by the parasite, with numerous
metabolites varying in phase with the developmental
cycle. Others differed from uninfected cells irrespec-
tive of the developmental stage. Among these was
extracellular arginine, which was specifically con-
verted to ornithine by the parasite. To identify the
biochemical basis for this effect, we disrupted the
plasmodium arginase gene in the rodent malaria
model P. berghei. These parasites were viable but
did not convert arginine to ornithine. Our results
suggest that systemic arginine depletion by the para-
site may be a factor in human malarial hypoarginine-
mia associated with cerebral malaria pathogenesis.
INTRODUCTION
Infection by the malaria parasite Plasmodium falciparum has
severe and potentially lethal consequences for the metabolic
state of the human host (Planche et al., 2005). The approximately
500 million cases of this devastating disease lead each year to
1–2 million deaths worldwide (Sachs and Malaney, 2002). In all
parasitic infections there is a significant metabolic interaction
between pathogen and host as the parasite diverts nutrients
toward itsowngrowthwhile the host struggles tomaintainhomeo-
stasis and cope with waste products, toxins, and tissue damage.
In the case of P. falciparum-induced malaria, the metabolic
demands of the rapidly proliferating parasite cells, coupled with
the effects of massive erythrocyte lysis and ischemic damage
arising from the sequestration of parasitized erythrocytes within
the microvasculature, are responsible for the pathogenesis of
the disease and its manifestations (Mackintosh et al., 2004). TheseCell Hoclinical manifestations include hypoglycemia, lactic acidosis,
hemolytic anemia, hemoglobinuria, and hypoargininemia.
The metabolites required by cells for macromolecular synthesis
and growth are either acquired directly by uptake from the
environment or else biosynthesized from the pool of available
nutrients. Free-living protozoa maintain a versatile and dynami-
cally regulated metabolic network that can support optimal
growth from a wide variety of nutrient sources. In contrast, obli-
gate intracellular parasites of mammals are restricted to a much
more homeostatic and nutrient-rich environment and might be
expected to have adapted to this specific milieu by altering the
architecture of their metabolic network to maximize growth at
the cost of flexibility. Within the human host,P. falciparum is found
mostly within mature erythrocytes in the nutritionally complex
environment of the bloodstream, and a wealth of evidence
suggests that the metabolism of these blood-stage parasites
has diverged significantly from well-studied model eukaryotes
such as yeast.
Upon invading an erythrocyte, the parasite induces major
modifications to the host cell to permit the directed exchange
of metabolites (reviewed in Kirk et al., 2005). New permeability
pathways are induced on the host cell surface to enhance the
influx and efflux of specific compounds. The parasite also initi-
ates a catabolic process whereby hemoglobin from the erythro-
cyte cytoplasm is ingested and proteolyzed into its constituent
amino acids in an acidic vacuole (Krugliak et al., 2002). Extensive
genomic and biochemical evidence indicates that many areas of
parasite metabolism have been radically streamlined or modi-
fied. For example, Plasmodia have lost the ability to synthesize
the purine ring de novo, rendering them auxotrophs dependent
on the uptake of purine nucleotides and nucleobases from the
host (Gardner et al., 2002). These parasites are also incapable
of amino acid biosynthesis, relying instead on hemoglobin
catabolism and uptake from the extracellular space (Gardner
et al., 2002). Energy metabolism consists almost entirely of
glucose fermentation by the parasite to lactate, calling into ques-
tion the role of the parasite mitochondrion in energy generation
(Sherman, 1998). The function of the apicoplast, a nonphotosyn-
thetic plastid-like organelle, remains poorly elucidated, although
it is known to play a role in fatty acid, heme, and isoprenoid
biosynthesis (Ralph et al., 2004).
Due to the importance of plasmodial metabolism for malaria
pathogenesis and as a target for most current and candidatest & Microbe 5, 191–199, February 19, 2009 ª2009 Elsevier Inc. 191
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method that simultaneously assays for200 compounds of vali-
dated identity (Lu et al., 2006). We analyzed both parasite-
infected and uninfected red blood cell (RBC) cultures at seven
time points during development to determine the parasite-
induced alterations to normal RBC metabolism. The RBCs
(infected and uninfected) and the liquid culture medium were
collected and analyzed separately in order to profile the para-
site-induced changes to both the intra- and extracellular metab-
olite pools. Roughly 90 metabolites were detected with a signal
sufficient to construct temporal profiles of their relative levels
(Figures 1, S1, and S2 and Tables S1 and S2). These compounds
span a wide range of metabolic pathways and include amino
acids, nucleotides, biosynthetic precursors, and central carbon
metabolism intermediates. For comparative purposes, we also
measured global parasite mRNA levels in parallel by DNA
microarray analysis for all time points (Figure S3 and Table S3).
Due to the highly periodic nature of gene expression observed
during the IDC (Bozdech et al., 2003), we analyzed our metabo-
lite profiles for periodic fluctuation to determine if metabolic
requirements are also cyclical. Although many metabolite levels
were either unchanged or else varied monotonically throughout
the cycle, the subset shown in Figure 1A exhibited detectable
periodicity. Most of these metabolites show peak abundance
during the late trophozoite/early schizont stages, a period of
the IDC associated with high levels of energy metabolism and
macromolecular biosynthesis.
The P. falciparum metabolome reflects the radical metabolic
simplification that has occurred over its evolution toward a para-
sitic lifestyle. For example, we find no evidence for de novo
amino acid biosynthesis, consistent with extensive genomic
(Gardner et al., 2002) and biochemical (Krugliak et al., 2002)
evidence that the Plasmodia have essentially lost this capacity
entirely in favor of amino acid scavenging and hemoglobin
catabolism. The metabolites that are detected and that appear
by this analysis to be cell-cycle-regulated, are indicative of the
major metabolic processes that are known to be essential for
growth. For example, dihydro-orotate and orotate, intermediates
in the pyrimidine biosynthesis pathway, oscillate strongly in
phase with the IDC (Figure 1A). As the parasite’s sole source of
pyrimidine bases, this pathway is essential for growth and in
fact has been proposed to be the effective target of the antima-
larial drug atovaquone (Painter et al., 2007). Inosine-50-phos-
phate (IMP) follows a similarly periodic profile (Figure 1A). This
metabolite is the product of an early step in the salvage pathway
by which the Plasmodia, which are obligate purine auxotrophs,
acquire purine bases (Downie et al., 2008). These metabolites
reach their peak abundance coincident with a burst of nucleo-
sides and nucleoside monophosphates occurring 32–40 hr
postinvasion (Figure 1A), corresponding to the late trophozoite/
early schizont transition, in which the parasite successively
replicates its genome 16–32 times and nucleotide demand is
at its highest.
Energetically, it is well established that the Plasmodia rely
almost entirely on glycolysis and perform little or no oxidative
phosphorylation (Lang-Unnasch and Murphy, 1998). While the
parasites possess a mitochondrion, the mitochondrial genome
is the smallest sequenced to date, their oxygen consumption is
minimal, and there has been no clear evidence of a functionalantimalarial pharmaceuticals, it is critical that we understand
both the structure and dynamics of the parasite metabolic
network. Indirect approaches to reconstructing this network,
such as inference from genomic data or in vitro biochemistry,
are at best incomplete and present significant obstacles in the
case of highly diverged organisms. Metabolomic technologies
(Kell, 2004; Want et al., 2005), however, are beginning to enable
systems-level measurements of changes in metabolic activity
in response to genetic (Fischer and Sauer, 2003) and nutrient
(Brauer et al., 2006) perturbations, as well as drug treatments
(Nicholson et al., 2002) and other viral infections (Munger et al.,
2006).
One focus of recent metabolomic investigations has been the
nature of host-parasite interactions. Parasite pathogens and
their hosts are by definition metabolically intertwined, and the
pathology of many parasitic diseases is linked to dysregulation
of host metabolism. Several studies have examined the systemic
effects of parasite infection in vivo by nuclear magnetic reso-
nance analysis of host biofluids with the aim of elucidating meta-
bolic modulation by the parasite and identifying reliable
biomarkers to aid in the diagnosis of Schistosoma (Wang et al.,
2004), Trichinella (Martin et al., 2006), and Plasmodium (Li et al.,
2008) infection. These studies have uncovered a number of
significant effects that likely would not have been found by clas-
sical biochemical methods. In particular, an analysis of urine and
plasma from mice infected byPlasmodiumberghei (Li et al., 2008)
discovered evidence of a disturbance of the gut microbiota and
high levels of the lysine catabolic product pipecolic acid in host
urine, an effect that thus far appears to be specific to plasmodial
infection. Directed metabolomic experiments in cell culture have
also revealed critical aspects of parasite metabolism, such as an
apparent partitioning of carbon metabolism in the protozoan
Trypanosoma brucei into different regimes corresponding to
the differing nutrient availabilities in the mammalian and insect
host tissues (Coustou et al., 2008). Recently, NMR metabolomics
has also been used to determine the intracellular concentrations
of a range of metabolites in the P. falciparum trophozoite stage
(Teng et al., 2008). Applying metabolomic approaches to study
the dynamics of P. falciparum-infected erythrocyte metabolism
promises to similarly unravel some of the more poorly understood
aspects of parasite biology.
Understanding the plasticity of Plasmodium metabolism to
physiologically relevant perturbations will ultimately have great
clinical relevance in light of the possibility that parasites experi-
ence dramatically different metabolic states within the human
host, and the fact that certain front-line drugs, such as artemisi-
nin and its derivatives, act via an entirely unknown mechanism.
We have taken the initial step toward this goal by conducting
a metabolomic study of the complete intraerythrocytic develop-
mental cycle (IDC) of the most virulent human malaria parasite,
Plasmodium falciparum.
RESULTS
P. falciparum-Infected Red Blood Cell
Metabolite Analysis
We have quantitatively measured the levels of known metabo-
lites in synchronized cultures of P. falciparum (3D7 strain) over
the course of its 48 hr blood-stage developmental cycle using avier Inc.
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Plasmodium falciparum MetabolomicsFigure 1. Periodic Metabolite Fluctuation during the Intraerythrocytic Developmental Cycle
(A) Profiles of 29 intracellular metabolites with periodic changes in relative levels. Relative levels are expressed as the mean-centered log ratio of the normalized
signal intensity in the infected RBC extract at each time point (XI;N/ X). Profiles are ordered by the timing of their peak abundance level, from early (top) to late
(bottom).
(B) Temporal profile of relative levels of a-ketoglutarate and 5-methylthioinosine (5-MTI) levels in RBC (blue lines) and infected RBC (red lines) extracts over
the IDC. Shown for comparison are the gene expression profiles of the associated enzymes isocitrate dehydrogenase (IDH), adenosine deaminase (ADA),
and purine nucleoside phosphorylase (PNP) as determined by DNA microarray analysis. The error is given as the SD of n = 3 independent biological repli-
cates.
(C) Schematic of the developmental stages during the 48 hr IDC.Cell Host & Microbe 5, 191–199, February 19, 2009 ª2009 Elsevier Inc. 193
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(van Dooren et al., 2006). Strikingly, however, we observe coin-
cident peaks in the TCA-cycle intermediates citrate, aconitate,
and a-ketoglutarate during the trophozoite stage (Figure S4).
Malate exhibited a periodicity score slightly below our signifi-
cance threshold but is also most abundant during this stage.
The P. falciparum genome encodes all the necessary enzymes
to run a complete TCA cycle, and all are expressed during the
IDC (Figure S4) (Bozdech et al., 2003); these data suggest that
the enzymes are also active. In light of the recent observation
that the sole pyruvate dehydrogenase encoded by the P. falcipa-
rum genome localizes to the apicoplast, where it presumably
generates acetyl-CoA exclusively for fatty acid biosynthesis
(Foth et al., 2005) instead of the TCA cycle, these data suggest
TCA metabolism may be more complex and important
than previously realized and is a promising candidate for future
study.
Within the set of nonperiodic metabolites, we find a substantial
increase in the NAD+ content of infected RBCs, consistent with
previous literature (Zerez et al., 1990). These high NAD+ levels
are supported in part by biosynthesis from the precursor nicotin-
amide, which is significantly depleted from the culture medium
during the late trophozoite/schizont stage of the life cycle
(Figure S5). Elevated NAD+ levels have been suggested to be
necessary to support the increased glycolytic flux in infected
RBCs (Zerez et al., 1990). This flux upregulation is evident in
our data as an increase in the relative rates of glucose consump-
tion and lactate generation (Figure S5). These results agree with
genomic data that suggest that P. falciparum should be entirely
dependent on exogenous nicotinamide or nicotinic acid for
NAD+ biosynthesis (Gardner et al., 2002) and highlight either
the uptake or synthesis pathway as a potential drug target.
Metabolite and mRNA Transcript Abundance
during Development
To better understand the relationship between gene expression
and metabolite levels, we calculated the correlations between
each intracellular metabolite profile and the mRNA expression
profile of the enzymes involved in its formation or degradation
(Table S4). Only a subset of metabolite-enzyme pairs are signif-
icantly correlated or anticorrelated. The strongest correlation
was observed between 5-methylthioinosine (5-MTI), an interme-
diate in a Plasmodium-specific purine recycling pathway (Ting
et al., 2005), and the upstream enzyme adenosine deaminase,
although 5-MTI also correlates well with its downstream enzyme
purine nucleoside phosphorylase (Figure 1B). Interestingly,
a-ketoglutarate falls into this set due to its high correlation with
isocitrate dehydrogenase (Figure 1B). No significant correlation
is found between a-ketoglutarate and glutamate dehydroge-
nase, despite the presumptive major role of this enzyme in
a-ketoglutarate formation. This points to the possibility that,
despite the possibly noncanonical nature of the plasmodium
TCA cycle, intracellular a-ketoglutarate levels are strongly
impacted by the activity of canonical TCA cycle enzymes.
Arginine Is Rapidly and Specifically Depleted
from the Culture Medium
P. falciparum digests up to 75% of its host cell hemoglobin (Hb)
over its IDC to supply amino acids for protein synthesis and clear194 Cell Host & Microbe 5, 191–199, February 19, 2009 ª2009 Elsespace within the host cell (Krugliak et al., 2002). Although the
parasite lacks any capacity for de novo amino acid biosynthesis
(Gardner et al., 2002), this process generates sufficient amounts
of most amino acids to sustain growth even in the absence of
external supplementation (Liu et al., 2006). We find that intracel-
lular levels of the amino acids that are most abundant in hemo-
globin (alanine, valine, and histidine) all rise significantly in the
trophozoite stage, coincident with the initiation of hemoglobin
digestion (Figure S1). These amino acids also accumulate in the
extracellular medium, consistent with the observation that the
parasite incorporates only a fraction of the Hb-derived amino
acids into protein, excreting the excess as waste (Figures 2A
and S2).
The most dramatic relative change in extracellular amino acid
levels occurs for the nonproteogenic amino acids ornithine and
citrulline, which accumulate substantially in the medium during
trophozoite and schizont stages (Figure 2A). These amino acids
are generally derived from arginine, which is significantly depleted
over the same time interval (Figure 2A). Standard RPMI 1640
medium used for Plasmodium culturing contains 1.15 mM argi-
nine, which representsan 8- to 10-fold excess over normal human
serum arginine levels (Lopansri et al., 2003). However, previous
studies have concluded that arginine is unnecessary to support
optimal parasite growth (Liu et al., 2006), which suggests that
the parasite acquires sufficient quantities of arginine from hemo-
globin digestion. This raises the question of the origin and nature
of the observed effect on arginine and its downstream metabo-
lites. Intriguingly, several clinical studies have demonstrated
a strong correlation between reduced plasma arginine levels
and advanced malaria in both child and adult malaria patients (Lo-
pansri et al., 2003; Yeo et al., 2007).
Arginine Depletion Is Due to Arginase
When we measured arginine, ornithine, and citrulline levels in
a time course initiated during the trophozoite stage, arginine
levels were depleted to almost undetectable levels over 40 hr
(>100-fold down) (Figure 2B). In eukaryotic systems, there are
several enzymes that can interconvert between arginine, orni-
thine, and citrulline, including arginase, nitric oxide synthase
(NOS), and ornithine transcarbamylase. To determine which of
these might be responsible for the observed effect, we cultured
parasites in RPMI 1640 supplemented with equimolar amounts
of unlabeled and uniformly 13C15N-labeled L-arginine. After
40 hr, the only labeled form of ornithine detected was the fully
13C15N-labeled form (Figure 3A). Fully labeled ornithine can be
generated from fully labeled arginine directly by arginase-cata-
lyzed hydrolysis of arginine to ornithine and urea, or indirectly
by the action of a citrullinase on fully labeled citrulline to yield
ornithine and ammonia. There is no recognizable citrullinase in
the P. falciparum genome, but an arginase (PFI0320w) has
been cloned and characterized (Muller et al., 2005). We therefore
identify this enzyme as the likely source of extracellular ornithine.
We also detected fully labeled citrulline, which might derive
from labeled arginine via the removal of the terminal nitrogen
atom by either NOS (yielding nitric oxide) or arginine deiminase
(yielding ammonia). Neither of these enzymes is predicted in
theP. falciparum genome, but human RBCs contain NOS protein
that has been shown to be active under some circumstancesvier Inc.
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(A) Profiles of the 16 amino acids measured in culture medium samples. Relative levels are expressed as the background-subtracted log ratio of the normalized
signal intensity in the infected RBC sample at each time point (XI;N) to the normalized signal intensity in the uninfected RBC time 0 sample (XU;0). Amino acids are
ordered by the log ratio of the final time point, from highest (accumulating) (top) to lowest (depleting) (bottom).
(B) Arginine and ornithine concentrations in the culture medium of a 40 hr culture. A synchronized culture (6% initial parasitemia) was adjusted to 1% hematocrit in
fresh RPMI 1640 culture medium at the trophozoite stage (approximately 24 hr postinfection) and incubated 40 hr in parallel with an uninfected RBC control
culture. Concentrations were determined by LC-MS/MS analysis using an internal standard solution containing known concentrations of isotopically labeled
arginine and ornithine. The error is given as the SD of n = 3 independent biological replicates.(Kleinbongard et al., 2006). However, ornithine accounts for the
majority of the depleted arginine (Figure 2B).
The P. falciparum Arginase Is Responsible
for Arginine Turnover
TheP. falciparum arginase I homolog (Muller et al., 2005) contains
no recognizable targeting or export signal motifs and is most
highly expressed during ring and schizont stages (Bozdech
et al., 2003). However, mature human erythrocytes also contain
active arginase I (NP_000036), and we observe arginine depletion
and ornithine formation in uninfected blood cultures, although
to a much lower degree (Figure 2B). One explanation for the
enhanced arginase activity in parasite-infected cultures is the
release of host arginase during RBC lysis, permitting continuous
degradation of the extracellular arginine pool. This lysis-medi-
ated effect has been proposed to explain the observed hypoargi-
ninemia in sickle-cell disease patients (Morris et al., 2005) due to
the rupturing of sickled erythrocytes. To test the contribution of
RBC lysis to in vitro arginine degradation, we incubated a culture
consisting of uninfected RBCs that had been uniformly disrupted
by hypotonic lysis in parallel with an infected RBC culture. The
ornithine levels in the lysate culture were significantly lower
than in the infected RBC culture, demonstrating that even
100% RBC lysis is insufficient to account for the high level of argi-
nase activity (Figure 3B). This implicates the parasite arginase as
the major factor in arginine depletion.
Arginase Knockout Parasites Exhibit Background
Arginine Degradation Rates
To further test this hypothesis, we generated an arginase
knockout (argKO) line of the mouse parasite PlasmodiumCell Hosberghei (ANKA strain) via site-specific recombination (Figure S6).
The argKO line exhibited a slight delay in ascending parasitemia,
but mice infected with WT and argKO consistently developed
comparably high blood parasitemias (Figure S7) and exhibited
no difference in the onset of morbidity, establishing that the para-
site arginase is not essential for in vivo growth during the IDC.
When cultured ex vivo, WT P. berghei exhibited high levels of
ornithine generation, while ornithine generation by argKO para-
sites was indistinguishable from that of uninfected RBCs
(Figure 4A). Energy metabolism, as measured by lactate excre-
tion, was highly similar in WT and argKO parasites (Figure 4B);
the slightly elevated lactate levels in the argKO 12 hr time point
may reflect the added energetic demand of generating ornithine
by an alternative pathway, such as proline degradation. Thus,
high levels of arginase activity are found in a murine malaria para-
site as well, but the enzyme does not significantly contribute to
in vivo growth and thus may serve a secondary purpose.
DISCUSSION
Host-pathogen interactions rely heavily on an exchange of
nutrients between the host cell and the infectious agent. Using
a comprehensive mass spectrometry-based approach, we have
demonstrated that development ofPlasmodium falciparumwithin
RBCs modulates the levels of dozens of compounds from most
major metabolic processes, including amino acid and nucleotide
metabolism, energy generation, and cellular redox potential.
These data suggest a complex interplay between the host RBC
and the parasite for nutrient acquisition, turnover, and waste
removal.t & Microbe 5, 191–199, February 19, 2009 ª2009 Elsevier Inc. 195
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Previous studies in rodent malaria models have found that,
upon Plasmodium infection, the expression and activity of NOS
is induced in activated macrophages (Tachado et al., 1996).
Depletion of the plasma arginine pool may suppress this im-
mune response by removing the substrate for NO production.
In addition, the excess ornithine generated could exert a further
suppressive effect by competing with arginine for transporter-
mediated uptake into macrophages. A similar strategy is em-
ployed by the enterobacterium Helicobacter pylori, which uses
its arginase to deplete the host arginine pool and ablate the
NOS response (Gobert et al., 2001). However, while NO directly
suppresses H. pylori infection by killing the bacteria, this does
not seem to be the case with Plasmodium. Reactive nitrogen
intermediates have been shown to have direct antiparasitic
activity in vitro, but only at concentrations orders of magnitude
above physiological levels (reviewed in Sobolewski et al.,
2005). In addition, a study using NOS-deficient mouse lines
established that host NO production does not affect the prolifer-
ation of asexual-stage parasites (Favre et al., 1999). However,
NO does inactivate the more vulnerable sexual-stage gameto-
cytes that are generated during the IDC and taken up by the
mosquito host (Naotunne et al., 1993). This pathway may have
evolved as a means for the more abundant and metabolically
active asexual parasites to protect gametocytes from NO-medi-
ated inactivation, increasing infectivity and allowing for more
efficient propagation. The need to protect gametocytes from
Figure 4. Phenotypic Analysis of the P. berghei Arginase Knockout
Strain
(A) Ornithine levels in the culture medium of a 24 hr ex vivo culture (10% para-
sitemia, 1% hematocrit).
(B) Lactate levels from the same experiment. The p values give the significance
of difference between the ANKA- and argKO-infected RBC samples (*p < 0.01;
**p < 104; ***p < 0.05). The error is given as the SD of n = 3 independent
biological replicates.Specifically, we have identified a rapid and specific degrada-
tion of arginine deriving from the plasmodial arginase. A major
metabolic activity of arginases in protozoa is the generation
of ornithine for polyamine biosynthesis (Kropf et al., 2005).
However, this requirement seems unlikely to account for the
high levels of observed activity for two reasons: first, the vast
majority of the metabolized arginine is excreted into the extracel-
lular environment, not selectively retained in the cell; second, the
growth rate is not affected by the absence of arginine in the
culture medium, suggesting that arginine is not rate-limiting for
growth in vitro (Liu et al., 2006). The argKO parasites presumably
acquire sufficient amounts of ornithine either from the plasma or
the activity of the host cell arginase.
An alternative model is that the parasite depletes the host argi-
nine pool in order to modulate the activity of the host enzyme,
NOS. NOS is used by the mammalian immune system to
Figure 3. Arginine Depletion Is Due to the P. falciparum Arginase
(A) P. falciparum was cultured for 40 hr in RPMI 1640 medium supplemented
with equimolar amounts (1.15 mM) of unlabeled and U-13C15N-labeled argi-
nine. Culture medium samples were analyzed by LC-MS/MS for labeling in
metabolites downstream of arginine. Shown are the signal intensities for unla-
beled (gray) and U-13C15N-labeled (black) ornithine and citrulline. These were
the only forms detected for either amino acid.
(B) Uninfected RBCs were uniformly lysed in distilled H2O, diluted to 1%
hematocrit in RPMI 1640, and incubated alongside a P. falciparum culture
(1% hematocrit, 6% initial parasitemia, trophozoite stage). After 40 hr, medium
samples were collected and analyzed by LC-MS/MS. Shown are concentra-
tions of arginine and ornithine in untreated RPMI medium (white bars), RPMI
medium mixed with the RBC lysate for 40 hr (gray bars), and the extracellular
medium from an infected RBC (iRBC) culture grown for 40 hr in RPMI (black
bars). The error is given as the SD of n = 3 independent biological replicates.vier Inc.
Cell Host & Microbe
Plasmodium falciparum MetabolomicsNO may become more acute for P. falciparum because of the
longer period (14 days) necessary for their maturation, during
which the parasite needs to remain sequestered from circulation.
A further consequence of hypoargininemia and low host NO
levels may be the upregulation of host endothelial cell surface
receptors such as ICAM-1 (intracellular adhesion molecule 1),
which increases the ability of the parasitized RBCs to cytoadhere
to the vascular endothelium and thus avoid passage through the
spleen and clearance (Sherman et al., 2003).
There is substantial evidence linking hypoargininemia to malar-
ial infection and progression to cerebral malaria (Gramaglia et al.,
2006; Lopansri et al., 2003; Yeo et al., 2007), but the origin of this
effect has not been established to date. Previously proposed
explanations included dietary deficiencies, defects in arginine
transport or biosynthesis, and the activity of the free host argi-
nase (Gramaglia et al., 2006; Lopansri et al., 2003). Additionally,
arginine levels are strongly regulated during the host inflamma-
tory response, and hypoargininemia is a hallmark of both patho-
genic inflammations, such as bacterial sepsis, and those due to
traumatic insult (Satriano, 2004). Our results, however, demon-
strate that the Plasmodium arginase plays a significant role in
arginine depletion (at least in vitro) and that disruption of the
parasite enzyme ablates this effect without compromising
in vivo viability. It has recently been reported that diminished
NO bioavailability plays a critical role in the onset of experimental
cerebral malaria (ECM), leading to mortality (Gramaglia et al.,
2006). The same study also found that hypoargininemia corre-
lated with disease progression. This, coupled with a similar result
from a clinical study of human cerebral malaria (Lopansri et al.,
2003), suggests thatPlasmodium arginase could be an important
factor in cerebral malaria pathogenesis, although the observation
that plasma arginine levels in patients with severe malaria (which
includes a substantial parasite burden in the blood) are not signif-
icantly different than in those with moderately severe malaria (Yeo
et al., 2007) highlights the likely multifactorial nature of arginine
regulation. Arginine supplementation has recently been shown
to improve endothelial function and increase exhaled NO levels
in clinical malaria patients (Yeo et al., 2007). Our results suggest
that a combination therapy that incorporates a parasite arginase
inhibitor may be a promising target for future investigation.
Metabolomic analysis promises to significantly deepen our
understanding of Plasmodium biology and the malaria disease
state. It will be useful in determining the metabolic differences
between phenotypically divergent strains and in elucidating the
mechanism of action for poorly characterized drugs, by mapping
responses at the metabolic level that are undetectable by such
methods as microarray analysis. The ability to generate concur-
rent metabolomic and transcriptomic profiles will allow investiga-
tion of the relationship between enzyme expression and metab-
olite level. A recent analysis of the transcriptional profiles of
P. falciparum isolated from clinical malaria patients suggested
that in vivo parasites may exist in distinct physiological regimes
corresponding to stress or starvation states that have not been
observed in ex vivo cultures (Daily et al., 2007). As metabolic
enzymes represent a significant portion of the genes differentially
regulated between these states, metabolomic investigations of
patient samples might significantly advance our understanding
of malarial pathogenesis within the human host. Furthermore,
this experimental system will provide a powerful tool to furtherCell Hoinvestigate clinically important biochemical pathways in greater
detail and elucidate the metabolomic response to physiologically
relevant perturbations such as nutrient limitation, heat shock, and
drug exposures.
EXPERIMENTAL PROCEDURES
P. falciparum Culturing and Metabolite Extraction
P. falciparum cultures were maintained and synchronized by standard methods,
with slight modifications outlined in the Supplemental Data. RBCs (infected or
uninfected) were pelleted and immediately serially extracted, first with four
volumes of 100% methanol at 75C for 15 min, then twice with one volume
80:20 methanol:water at 4C. For the second and third extractions, the mixture
was sonicated15min on ice ina water bathsonicator. The culture mediumsuper-
natants from each extraction were pooled and centrifuged free of cell debris and
protein. Supernatants were diluted in 4 volumes of 100% methanol at75C and
centrifuged. Samples were analyzed within 24 hr of their generation.
LC-MS/MS Instrumentation
LC-MS/MS was performed using a Shimadzu LC-10A HPLC system and a Phe-
nomenex Luna aminopropyl column (250 mm3 2 mm with a 5 mm particle size)
coupled to a Thermo Electron Corporation Finnigan TSQ Quantum Ultra triple
quadrupole mass spectrometer. The data presented are means ± SD for n = 3
biological replicates. Data extraction, treatment, periodicity, and microarray
correlation analyses are described in the Supplemental Data.
DNA Microarray Analysis
For each time point, 0.5 ml of packed RBC (10% parasitemia) was pelleted by
centrifugation, washed once in PBS, and flash-frozen in liquid nitrogen. Total
RNA isolation and aminoallyl cDNA labeling were as previously described
(Bozdech et al., 2003). A pool of 3D7 total RNA from all IDC stages was gener-
ated as the reference sample. Microarray data have been deposited at the
NCBI Gene Expression Omnibus (GEO) under accession number GSE14524.
Parasite Infections
Donor BALB/c mice were injected with P. berghei ANKA WT or argKO stabi-
lates. Parasitemia was monitored by examining blood films. Donor mice
infected with argKO parasites were treated with 10 mg/kg pyrimethamine
once parasites were detectable.
Generation of ArgKO P. berghei
To generate the pL0001.1 knockout vector, DNA fragments flanking the
predicted P. berghei ortholog of Pfi0320w (Pb000787.03.0) were cloned into
the vector pL0001 flanking the pyrimethamine selectable marker Toxoplasma
gondii DHFR-TS. Linearized plasmid DNA was transfected and pyrimeth-
amine-resistant parasites recovered from BALB/c mice. Locus disruption
and clonality of the population was verified by Southern blotting (Figure S6).
Ex Vivo Short-Term Cultures of P. berghei
Blood from infected BALB/c mice with 20%–30% parasitemia was collected in
HEPES-buffered saline containing 10 U/ml heparin. Cells were centrifuged and
resuspended in RPMI 1640 medium containing 20% fetal calf serum and 0.5%
Albumax. Parasitemia was adjusted to 10% by dilution with uninfected RBCs.
Cultures were set up in triplicate at 1% hematocrit in 24-well plates and incu-
bated in chambers gassed with 90% N2, 5% O2, and 5% CO2. Samples were
collected at 0, 12, and 24 hr for metabolomic analysis.
SUPPLEMENTAL DATA
Supplemental Data include SupplementalExperimentalMethods,Supplemental
References, seven figures, and five tables and can be found online at http://
www.cell.com/cellhostandmicrobe/supplemental/S1931-3128(09)00031-6.
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